Galderma Announces FDA Approval of Restylane® Refyne and Restylane® Defyne Dermal Fillers for Treatment of “Laugh Lines”
Next-generation flexible hyaluronic acid dermal fillers provide natural-looking results through XpresHAn Technology
Fort Worth, TX – (December 12, 2016) – Galderma, a global leader focused on medical solutions in skin health, announced today it has received U.S. Food and Drug Administration (FDA) approval of two new products for the treatment of nasolabial folds (NLF) or “laugh […]
